GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pideka Group Inc (OTCPK:CIMVF) » Definitions » Research & Development

Pideka Group (Pideka Group) Research & Development : $ Mil (TTM As of Sep. 2021)


View and export this data going back to 2021. Start your Free Trial

What is Pideka Group Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Pideka Group's Research & Development for the three months ended in Sep. 2021 was $0.00 Mil. Pideka Group does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Sep. 2021.


Pideka Group Research & Development Historical Data

The historical data trend for Pideka Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pideka Group Research & Development Chart

Pideka Group Annual Data
Trend
Research & Development

Pideka Group Quarterly Data
Mar20 Jun20 Sep20 Mar21 Jun21 Sep21
Research & Development Get a 7-Day Free Trial - - - - -

Pideka Group Research & Development Calculation

This is the expense the company spent on research and development.


Pideka Group  (OTCPK:CIMVF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Pideka Group Research & Development Related Terms

Thank you for viewing the detailed overview of Pideka Group's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Pideka Group (Pideka Group) Business Description

Traded in Other Exchanges
N/A
Address
40 King Street West, 2100 Scotia Plaza, Toronto, ON, CAN, M5H 3C2
Pideka Group Inc is multi-national operator with a medical grade indoor cultivation facility and laboratory in Colombia which holds GMP-PHARMA and good agricultural and collection practice certifications, and a retail operation in California.